About Volta
Non Dispersed Electrocardiograms
Dispersed Electrocardiograms
1
dispersion location
Multipolar electrogram abnormality associated with the perpetuation of atrial fibrillation. Red: highly dispersed electrograms, Orange: dispersed electrograms, Blue: non-dispersed electrograms.
2
mapping catheter
Steerable, multipolar electrode catheter. Allows for the recording of the local electrical activity.
3
reference cycle length
Atrial cycle length estimated from recordings obtained with the coronary sinus catheter.
4
mapping cycle length
Local cycle length estimated from real-time recordings obtained with the mapping catheter.
1
dispersion location
Multipolar electrogram abnormality associated with the perpetuation of atrial fibrillation. Red: highly dispersed electrograms, Orange: dispersed electrograms, Blue: non-dispersed electrograms.
2
mapping catheter
Steerable, multipolar electrode catheter. Allows for the recording of the local electrical activity.
3
reference cycle length
Atrial cycle length estimated from recordings obtained with the coronary sinus catheter.
4
mapping cycle length
Local cycle length estimated from real-time recordings obtained with the mapping catheter.
Compliance
Patient privacy: All data collected is anonymized or pseudonymized in compliance with Data Protection regulations. Notably, data undergoes a state-of-the-art encryption (dual process, dual keys). Our policy meets the highest standards of data protection.
CE marked & FDA cleared: Volta’s VX1 software solution is the first AI-based solution in the interventional cardiology space to have obtained FDA clearance and CE marking.
Technology
Real time analysis: VX1 provides state-of-the-art analysis in real-time, ensuring optimal usability.
Precision: its integration allows for high density mapping in both atria.
Intellectual Property: Volta’s technology is protected internationally with multiple patents.
Data Driven: VX1 algorithm has been trained on large, carefully curated databases. Our goal is to mimic the expertise of trained physicians and reduce inter-operator variability in identifying specific abnormal electrograms.
Compatibility
Most multipolar mapping catheters
Two EP recording systems
Most 3D navigation systems
VX1. vs. Trained Expert Cardiac Electrophysiologists
Conclusions
SOURCE: HRS 2020 Imagineer Tech Showcase.
-
The clinical significance of utilizing the VX1 software to help identify areas with intra-cardiac atrial electrograms exhibiting spatiotemporal dispersion
for catheter ablation of atrial arrhythmias, such as atrial fibrillation, has not been established by clinical investigations.
Our team
Management
Team
El Makki Voundy
Full-Stack Developer
Fabienne Pouplier
DPO
Mohsen Shah
US Business Development Manager
Daniel Guerrero
US Clinical Operation Manager
Didier Villevalois
Full-Stack Developer
Philippe Tartaise
Lead Developer
Julien Seitz
President, co-founder
+
Julien Seitz
President, co-founder
Julien is the acting Chief of the cardiac electrophysiology section at Saint Joseph Hospital (Marseille, France).
St-Joseph hospital is one of the three highest-volume ablation center in the country. This gave him many opportunities to think deep about what interventional cardiologists need most. Julien is well-known for his contributions to the field of electrogram-based ablation. He has published plenty of manuscripts in high-impact cardiology journals. He is a regular guest speaker, chairman at major conferences.
Since he started as an interventional cardiologist, Julien has been obsessed with making accessible any complex ablation approach to large numbers of colleague physicians. He started with conceptualizing multipolar-electrogram visual interpretation into a series of simple steps.
Since Volta was created, he used his in-depth experience to help design AI algorithms that provide simple but powerful cues to cardiologists.
Théophile Mohr Durdez
CEO, co-founder
+
Théophile Mohr Durdez
CEO, co-founder
Théophile grew up in France, Germany and Austria. Since his young age, he wanted to help his fellow humans with technology. Latter on, he studied at Ecole polytechnique (Paris), where he fell in love with Statistics, Machine and Deep Learning. There, he obtained a double degree with the Business School HEC (Paris).
His first accomplishment was to create a wheelchair controlled via eye-tracking for SLA disabled people. He then helped in solving complex geophysics with the use of differential equations.
In 2016, he co-founded Volta, where he was the passionate architect and inventor of Volta’s algorithms. In 2017, Théophile received the Research Award from Ecole polytechnique for the algorithms that he developed at Volta.
Théophile is hiring and leading a team of top-talents to drive Volta towards success by making a difference for operators and patients.
Clément Bars
VP, co-founder
+
Clément Bars
VP, co-founder
Clément has devoted his career to refining his understanding of procedural work flows in the field of cardiovascular electrophysiology.
Clement has become a well-known expert at simplifying work flows, specifically as they pertain to atrial fibrillation catheter ablation. His many contributions to the field of ablation could be summarized as “Do what you understand well, but keep it simple”.
He is regularly invited as a guest speaker or as a proctor in major hospitals in Europe, USA and Asia.
At Volta, he oversees the clinical evaluation of Volta’s algorithms. With more than 40 cardiac electrophysiologists visiting us last year alone, Clément has formed a large network of interventional cardiologists that cannot wait to try Volta’s algorithms.
Sabrina Siame
Clinical Research Assistant
Aman
Business Analyst
Loren Siry
HR Manager
Dinara Veshchezerova
Data Scientist
Mélanie Reist
Field Technical Engineer
Meryem Serdi
Field Technical Engineer
Maxime Basset
Field Technical Engineer
Paola Milpied
VP Clinical & Regulatory Affairs
+
Paola Milpied
VP Clinical & Regulatory Affairs
Paola is a former engineer and data scientist who holds a PhD in signal processing and machine learning applied to Cardiology. She has 13+ years of experience in medical device companies in France and in the US where she held several roles in clinical research and regulatory affairs in the cardiovascular field.
At Volta, Paola leads the clinical, quality and regulatory affairs department with an ambitious clinical program as well as major regulatory challenges.
Yoann Dutil
QMS Compliance Manager
Audrey Balzano
Executive Assistant
Quentin Taburet
Data Scientist
Thomas Boudou
Data Scientist
Camille Schmisser
Clinical & Regulatory Affairs Specialist
Idriss Lopes Sanches
Developer
Aurélien Rosiau
Full-Stack Developer
Vianney Guesdon-Vennerie
Front-End Developer
Denis Hansjacob
COO
+
Denis Hansjacob
COO
After more than 30 years as a high-level executive in the Biomedical Device Industry, Denis decided to join Volta to be part of the next wave of technology designed for the operating room.
Denis has been Managing Director of St. Jude Medical France and Vice-President for Northern Europe, where he led commercial operations. He has a unique understanding of marketing, sales and reimbursement mechanisms. Denis is helping Volta’s products spread quickly in Europe and the USA.
Also, Denis is shaping the future of biomedical devices revenue model. Denis is the proponent that AI is the best solution to cure more patients from AF in the best cost efficient way.
Anton Vorobev
CFO
+
Anton Vorobev
CFO
Anton is an HEC Paris graduate with experience in financial modeling, startup funding and business strategy.
He is co-founder and founder of several start-ups and he led regional operations for a Dutch IT company.
Anton’s business background allows for accelerating Volta’s international growth and helps Volta Medical with refining its financial strategy.
Jérome Kalifa
Chairman, CMO, co-founder
+
Jérome Kalifa
Chairman, CMO, co-founder
Both basic scientist and clinical electrophysiologist, Jérôme is based in the USA and currently Faculty at Brown University, Rhode Island, USA.
Jérôme dedicated about two decades to translational and clinical research in cardiac electrophysiology.
He is a seasoned speaker, chairman and reviewer for cardiology journals and conferences. His research effort has focused on understanding atrial fibrillation mechanisms as they pertain to cardiac interventions.
His background in cardiac mapping, imaging, database management and catheter technologies helped us design Volta’s algorithms.
Jérôme’s knowledge of the US clinical landscape is helping Volta address the needs of US users.
Anthony Appetiti
Head of Sales EU
Rebecca Sircoulomb
Head of product
Investors & Partners
Press releases
Volta Medical raises 23 million Euros to revolutionize persistent AF ablation
Volta Medical raises 23 million Euros to revolutionize persistent AF ablation
Marseille, 7 January 2021 – Volta Medical, a pioneering French-based HealthTech startup, working on novel artificial intelligence (AI) algorithms to treat cardiac arrythmias, today announced that it has successfully raised 23 million Euros. The financing round was led by Gilde Healthcare with participation of existing shareholder Pasteur Mutualité. The new capital will allow the company to establish its revolutionary FDA-cleared and CE marked VX1 AI software solution as a new standard of care, pursue further R&D activities and start to roll out commercial activities across the US and Europe. Recruitment for TAILORED-AF, an international multicenter trial has already started. Volta Medical will be welcoming two new Board members. Janke Dittmer, General Partner at Gilde Healthcare, has been nominated as a board member and former medical device industry top executive, Denis Gestin, as an independent board member.
After developing the first commercially available AI software to help electrophysiologists improve management of cardiac arrythmias, Volta Medical is now preparing to transform the way ablation procedures will take place in the future. Theophile Mohr-Durdez, CEO and co-founder of Volta Medical mentioned: “We are excited to be able to complete our highly ambitious medical program with the start of TAILORED-AF, a new randomized controlled trial (RCT). This trial aims to demonstrate how our AI software can help physicians optimize both efficacy and efficiency when performing complex procedures to treat heart rhythm disturbances.” Atrial fibrillation (AF) currently affects over 30 million patients worldwide. This underlines the importance of the TAILORED-AF trial which is likely to result in a breakthrough approach for tackling one of the world’s greatest public health challenges in a more consistent and reproducible manner. According to Gilde Healthcare’s Janke Dittmer, “We are excited to support Volta’s team in bringing a unique solution to address one of the biggest unmet needs in the large and fast-growing electrophysiology market”.
About atrial fibrillation (AF)
AF can be considered an “electrical storm” in the atria in which all synchronized activities have disappeared, and the necessary coordination of the contraction stops. This can lead to a number of symptoms including palpitations, shortness of breath, and in some patients, heart failure. AF is also a major risk factor for stroke, as stagnant blood in the atrium during AF may lead the formation of a clot, that can migrate to the brain. AF increases the likelihood of stroke by four to five times and AFib-induced strokes that are generally associated with more severe damage.
AF is an extremely costly public health problem. It affected approximately 6 million patients in the US in 2019 and 11 million patients in Europe in 2018 and prevalence is estimated to double by 2060. In Europe 120,000-215,000 new cases are projected to occur each year reaching a total AF patient population prevalence of 14-17 million by 2030. Evidence suggests a higher prevalence of AF in patients with hypertension, heart failure, coronary heart disease, obesity, diabetes. In addition, recent studies show that 20-30% of patients with ischemic stroke have had AF before, during or after the initial event.
The TAILORED-AF trial
TAILORED-AF is an international, multicenter trial designed to compare the VX1 AI software ablation strategy with currently used conventional anatomical ablation approaches. According to Dr Tom De Potter, Head of Electrophysiology, OLV Hospital, Aalst, Belgium and one of the TAILORED-AF trial investigators, “treatment of the more severe forms of drug-resistant persistent AF remains a major challenge in our field, both due to the large number of patients affected and lack of therapeutic strategies that can offer predictable efficacy. Thanks to the software’s ability to identify signals that are relevant, from those that are less relevant, one of its greatest and most unique benefits is to allow for a more easily reproducible approach to ablation.” The results of the Ev-AIAFIB proof of concept study carried out with VX1 in 8 different centers will soon be published. They will provide data on why and how this new approach has the potential to provide electrophysiologists with a guidance tool that will optimize treatment of patients with AF in a lasting manner.
Conventional ablation methods, while useful for treating patients, who cannot tolerate or who are resistant to anti-arrhythmic drug therapy, have so far been less precise than desired. Their results, even if significant in certain cases, remain sub-optimal. Localization and ablation of drivers perpetuating AF have been at the forefront of cardiovascular disease research but have not led to any radical changes to-date. Volta’s system is intuitive, user-friendly and shows promise to potentially reduce inter-operator variability in the analysis of procedural data without lengthening either the diagnostic or therapeutic procedures. “We are eager to help new centers access and use our revolutionary tool during ablation procedures. This cutting-edge medical innovation enhances the efficiency and precision of the practitioners who are analyzing real-time data in the operating room. Its robustness will help physicians adopt a more efficient workflow and take the right decisions” – claimed physician co-founder, Jerome Kalifa.
About Volta Medical
Founded by three physicians and a data scientist in 2016 in Marseille, Volta Medical is a HealthTech company developing AI software solutions to assist cardiac electrophysiologists in the operating room. Volta’s overarching goal is to drastically improve cardiac arrythmia management by developing state-of-the-art, data-driven medical devices based on large databases of procedural data with the highest standards of data protection. Its first product, VX1, assists cardiologists for the real-time identification of specific abnormal electrograms, known as dispersed electrograms.
For more information, visit the company’s website at www.volta-medical.com.
About the VX1 AI software
VX1 consists of a highly innovative AI algorithm that is compatible with most readily available multipolar catheters and technologies currently used in operating rooms or electrophysiology labs. The VX1 software analyzes the patient’s electrograms in real-time to identify specific electrograms known as dispersed electrograms. It also provides a cycle length estimation from electrograms recorded with the mapping and the coronary sinus catheters.
The clinical significance of utilizing the VX1 software to help identify areas with intra-cardiac atrial electrograms exhibiting spatiotemporal dispersion for catheter ablation of atrial arrhythmias, such as atrial fibrillation, has not been established by clinical investigations.
VX1 is a medical device which is FDA cleared and has a CE mark.
About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €1.4 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in fast growing companies active in digital health, MedTech and therapeutics. The venture & growth companies are based in Europe and North America. For more information, visit the company’s website at www.gildehealthcare.com.
Media Contacts
BCW agency
Linda Pavy – Tel: +33 (0)6 07 59 43 95 – Email: linda.pavy@bcw-global.com
Maëly Daviles – Tel: +33 (0)6 13 20 51 02 – Email: maely.daviles@bcw-global.com
Pauline Coudert – Tel +33 (0)6 88 38 46 58 – Email: pauline.coudert@bcw
References
1.https://globalheartjournal.com/articles/abstract/10.1016/j.gheart.2014.01.004/
2.https://www.ahajournals.org/doi/10.1161/strokeaha.115.012004
3.https://pubmed.ncbi.nlm.nih.gov/14966048/
4.Marco V. Perez, M.D., Kenneth W. Mahaffey, M.D., Haley Hedlin, Ph.D., John S. Rumsfeld, M.D., Ph.D., Ariadna Garcia, M.S., Todd Ferris, M.D., Vidhya Balasubramanian, M.S., Andrea M. Russo, M.D., Amol Rajmane, M.D., Lauren Cheung, M.D., Grace Hung, M.S., Justin Lee, M.P.H., et al., Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation, N Engl J Med 2019; 381:1909-1917
5.https://www.jnjmedicaldevices.com/sites/default/files/2020-07/Burden%20of%20Disease%20Full%20report.pdf
6.Krijthe, Bouwe P., et al. “Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.” European heart journal 34.35 (2013): 2746-2751.
7.2017 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016;37:2893–2962.doi:10.1093/eurheartj/ehw210
8.Authors/Task Force Members:, et al. “2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.” EP Europace 18.11 (2016): 1609-1678.
Volta Medical’s VX1 AI software for use in atrial fibrillation mapping now FDA cleared
Volta Medical’s VX1 AI software for use in atrial fibrillation mapping now FDA cleared
Marseille, December 10, 2020 –Volta Medical, a pioneering French-based HealthTech startup is pleased to announce that it has obtained FDA clearance for its revolutionary VX1 AI (artificial intelligence) software. This is the first FDA clearance for an AI based tool in interventional cardiac electrophysiology. VX1 is a machine and deep learning-based algorithm designed to assist operators in the real-time manual annotation of 3D anatomical and electrical maps of the human atria during atrial fibrillation (AFib) or atrial tachycardia. These annotations help physicians locate heart regions harboring a specific electrogram abnormality, known as spatiotemporal dispersion. This innovative detection and patient-specific localization of abnormal regions may eventually help physicians better decide where they need to intervene to either burn (radiofrequency) or freeze (cryotherapy) faulty electrical pathways.
According to Seth H. Goldbarg, MD, FACC, FHRS, Director of Cardiac Electrophysiology, New York Presbyterian/Queens, Assistant Professor, Weill Cornell Medical College, Flushing, NY, USA, “AFib represents a major challenge in cardiology due to the complexities associated with identification, localization and treatment of the pathological zones that cause and perpetuate this abnormal heart rhythm. The current standard of care does not provide us with a uniform, easy to follow and predictable approach to identify these regions. This has led to heterogenous approaches to treating these patients, with very mixed and often disappointing results. We are excited to be part of the further studies taking place with this AI software, as the VOLTA system may provide a major step forward in the effective approach to ablation of persistent AFib.”
Conventional ablation methods, while useful for treating patients, who cannot tolerate or who are resistant to anti-arrhythmic drug therapy, have so far been less precise in persistent AFib patients than desired. Their results, even if significant in certain cases, remain sub-optimal. Localization and ablation of drivers perpetuating AFib has been at the forefront of cardiovascular disease research but has not led to any radical changes to-date. The Volta mapping system is intuitive, user-friendly and shows promise to potentially reduce inter-operator variability in the analysis of procedural data without lengthening either the diagnostic or therapeutic procedures.
The VX1 system holds enormous promise for offering an easier, faster, more accurate and reliable way to identify zones of interest in patients who suffer from chaotic heart muscle contractions. Developed jointly by top experts in the fields of electrophysiology and digital technologies, VX1 is simple to use. It bears the potential to provide a permanent solution to a chronic health burden with a one-time breakthrough procedure and has the potential to become the gold standard AI solution, for efficient and affordable cardiac ablation procedures. For Jérôme Kalifa, MD and cofounder of Volta Medical “our ultimate goal is to offer an alternative to a lifetime of medication that can have problematic side effects in some patients, while bringing a better quality of life to those who suffer from bothersome daily disease symptoms. This is what is generating increasing enthusiasm around the potential of our solution. The recently obtained FDA clearance is an important milestone for our company and ultimately for patients who suffer from difficult to treat forms of AFib”.
About Volta Medical
Founded by three physicians and a data scientist in 2016 in Marseille, Volta Medical is a HealthTech company developing AI software solutions to assist cardiac electrophysiologists in the operating room. Volta’s overarching goal is to drastically improve cardiac arrythmia management by developing state-of-the-art, data-driven medical devices trained on large databases of procedural data with the highest standards of data protection. Its first product, VX1, assists cardiologists for the real-time identification of specific abnormal electrograms, known as dispersed electrograms.
For more information, visit the company’s website at www.volta-medical.com.
About the VX1 AI software
VX1 consists of a highly innovative AI algorithm that is compatible with most readily available multipolar catheters and technologies currently used in operating rooms or electrophysiology labs. The VX1 software analyzes the patient’s electrograms in real-time to identify specific electrograms known as dispersed electrograms. It also provides a cycle length estimation from electrograms recorded with the mapping and the coronary sinus catheters. The clinical significance of utilizing the VX1 software to help identify areas with intra-cardiac atrial electrograms exhibiting spatiotemporal dispersion for catheter ablation of atrial arrhythmias, such as atrial fibrillation, has not been established by clinical investigations. VX1 is a medical device which is FDA cleared and has a CE mark.
About atrial fibrillation (AFib or AF)
AFib can be considered an “electrical storm” in the atria in which all synchronized activities have disappeared, and the necessary coordination of the contraction stops. This can lead to a number of symptoms including palpitations, shortness of breath, and in some patients, heart failure. AFib is also a major risk factor for stroke, as stagnant blood in the atrium during AFib may lead to the formation of a clot, that can migrate to the brain. This is why AFib is such an important risk factor for heart failure and stroke and a major reason for loss of quality life.
AFib is expected to reach 12.1 million patients in the US by 2030. Prevalence of arrhythmias increases with age and total annual costs for treatment of AFib in the US were estimated already in 2001 at US$6.65 billion. Evidence suggests a higher prevalence of AFib in patients with hypertension, heart failure, coronary heart disease, obesity and diabetes. In addition, recent studies show that 20-30% of patients with ischemic stroke have had AFib before, during or after the initial event. AFib increases the likelihood of stroke by four to five times while AFib-induced strokes are generally associated with more severe damage.
Media Contacts
BCW agency
Linda Pavy – Tel: +33 (0)6 07 59 43 95 – Email: linda.pavy@bcw-global.com
Maëly Daviles – Tel: +33 (0)6 13 20 51 02 – Email: maely.daviles@bcw-global.com
Pauline Coudert – Tel +33 (0)6 88 38 46 58 – Email: pauline.coudert@bcw
References
1.https://www.cdc.gov/heartdisease/atrial_fibrillation.htm
2.https://www.uscjournal.com/articles/epidemiology-economic-burden-af
3.Authors/Task Force Members:, et al. “2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.” EP Europace 18.11 (2016): 1609-1678.
4.https://www.ahajournals.org/doi/10.1161/strokeaha.115.012004
Volta Medical raises $2.3M in seed funding to launch a European multicentric study, strengthen its R&D team and prepare the launch of VX1, its intelligent software.
Volta Medical raises $2.3M in seed funding to launch a European multicentric study, strengthen its R&D team and prepare the launch of VX1, its intelligent software.
Marseille (France) October 22, 2018
Volta Medical, a young French med‐tech company that has developed the first Artificial Intelligence (AI) software to guide cardiologists during heart surgeries, announces it has raised € 2.3 million euros in seed funding, including € 2 million from the Pasteur Mutualité Group. The funding round came on the heels of the first tests performed with patients in Marseille (France) and following the hiring of Denis Hansjacob, a prominent figure in the med‐tech industry, as Chief Operating Officer.
The funds raised will be used to implement a European multicentric clinical trial in order to demonstrate the performance of Volta Medical’s AI software during heart surgeries; to expand the company’s R&D team for the development of new products; and to prepare the market launch of AIFib in 2020. AIFib is the first AI software in interventional cardiology capable of guiding surgeons during their procedures, specifically for the treatment of atrial fibrillation (AF).
“Atrial fibrillation, AF, is a severe condition that decreases life expectancy and increases the risk and recurrence of strokes, as well as post‐stroke mortality. Our vision is to offer a solution to this major public health issue, and we thank the Pasteur Mutualité Group for trusting our innovative approach,” said Volta Medical’s four co‐founders, Dr. Julien Seitz, Dr. Clément Bars (Marseille), Dr. Jérôme Kalifa and engineer Théophile Mohr Durdez. “Our ambition, which is ideally aligned with the World Health Organization (WHO) program on heart diseases, is to help improve the treatment of atrial fibrillation – a condition whose prevalence increases as the world population ages – by bringing the artificial intelligence revolution to cardiologists and guiding them during their surgeries.”
“We are delighted to support Volta Medical, our very first investment in a young and promising start‐ up company. Volta Medical and its team hit all the right notes when it comes to our investment policy. They embody the core values of our Group and of the health professionals we serve, namely, the promotion of breakthrough innovation for the benefit of the greater medical community, including by significantly improving key treatments in the field of cardiology. From the company’s young, visionary founders to our mutualist Group, we are also very pleased with the positive approach taken during this operation, marked by a commitment to the evolution of the complex task of practicing medicine,” said Mr. Thierry Lorente, CEO of the Pasteur Mutualité Group.
Volta’s intelligent software, AIFib
AIFib is an AI software developed to guide doctors through the complex medical procedure intended to treat atrial fibrillation, from the detection of electrical foci, which trigger atrial fibrillation, to the surgery itself. Up until now, to identify electrical foci, cardiologists had to maneuver probes inside the heart as a way to identify electrical signals and detect them visually. Such technique is very hard to master, however, and surgeons had to analyze very complex sets of intracardiac electrical signals. Volta Medical had the idea of modeling and automating this technique to make it accessible to a large number of surgeons.
A clinical study is ongoing at Saint Joseph Hospital, in Marseille (France), to test the feasibility of the AIFib software during actual procedures. The initial data obtained on more than 30 patients are very promising and show that doctors’ expertise is either matched or outperformed by the AIFib software. The first results of the study are expected in the spring 2019.
Previous data presented in May 2018, at the annual Heart Rhythm Society Conference, in Boston, already showed that the performance of the software surpassed that of a panel of 28 cardiologists, including that of its creators, as recorded during a conference earlier this year in Marseille.
Atrial fibrillation (AF)
AF manifests itself by an anarchic, rapid and irregular heart rate. These chaotic heartbeats prevent the heart from properly pumping blood. The root cause is an “electrical storm” in the atria disrupting all synchronized activities, so that the mechanical contraction of the atria no longer occurs. The heart loses its strength. The ventricle may momentarily compensate for this loss, but in the long run, the exhaustion of its contractile forces can lead to heart failure. Atrial fibrillation can cause a blood clot in the heart, which may migrate into the brain arteries and cause a stroke.
This is the world’s most common heart arrhythmia and its prevalence increases with age, affecting 1 in 25 adults over 60 and 1 in 10 over 80. There are 7 million patients in the U.S., 11 million in Europe and 750,000 in France (the number of patients is expected to double within the next 30 years). A 55‐ year‐old person has 1 in 4 chances of developing AF during his lifetime (24.8% of men and 22.9% of women). It is therefore a true “epidemic.” AF is a severe disease that decreases life expectancy. AF is responsible for 1 in 6 strokes. The overall prevalence of AF is 5.5% of the population aged 55 and up, and it increases with age (10% at 80 and up). This is a major public health issue whose treatment costs 3,000 euros per year and per patient in France (2.5 billion euros per year in France, with hospitalization accounting for half the costs).
About Volta Medical
Founded in 2016 in the south of France by 3 doctors and one engineer, Volta Medical is a young med‐tech company based in Marseille that develops artificial intelligence (AI) intended for interventional cardiology. The 4 co‐founders are world‐renowned experts in cardiac electrophysiology and intracardiac signal analysis. It took them 10 years to develop a new state‐of‐the‐art medical procedure capable of guiding cardiac surgeons in the treatment of atrial fibrillation. Volta Medical will automate it thanks to the artificial intelligence software AIFib which has been developed by a highly skilled team of engineers and data scientists.
For more information: https://www.volta‐medical.com
About the Pasteur Mutualité Group
As a 160‐year‐old leading mutual insurance group managed by and intended to healthcare professionals, the Pasteur Mutualité Group is committed to helping its members, from the beginning of their studies, to provide them with solutions catered to the needs of their professional and private lives. Our DNA is marked by strong values of mutual assistance, respect and fairness. The spirit of our Group and its members is also the foundation of our strong Corporate Social Responsibility (CSR) investment policy. The Group places innovation at the heart of its development project. With more than 138,000 members, the Pasteur Mutualité Group is the preferred partner of healthcare professionals.
For more information: www.gpm.fr
Follow the Pasteur Mutualité Group on Twitter: @gpm_en
Heart diseases in numbers
French figures (Sources: Inserm)
✔ In France, heart diseases are responsible for 180,000 deaths every year
✔ Coronary artery diseases (including myocardial infarctions), strokes, and heart failures (HF) account for 27%, 25%, and 23% of all cardiovascular deaths, respectively. That does not include the sequelae and handicaps caused by heart diseases.
✔ In France, 120,000 people are treated each year for a myocardial infarction, 130,000 people for a stroke and about as much for HF.
World figures (Sources: WHO)
✔ Coronary artery diseases (ischemic diseases) and strokes are the leading cause of death worldwide. They accounted for a total of 15 million deaths in 2015.
✔ They have been the leading causes of death in the world for the past 15 years.
Press contacts
ALIZE RP
Caroline Carmagnol and Najette Chaib
+33 (0)6 64 18 99 59 / voltamedical@alizerp.com
Looking for new talents
Volta Medical brings together a team of top-talent dedicated to make a difference in the field of interventional cardiac electrophysiology.
Volta’s collaborators come from multiple countries and continents.
Our headquarters are located in Marseille. Marseille is in the South of France, on the Mediterranean sea. This creates a unique atmosphere, particularly prone to creativity and collaboration.
At Volta, we are convinced that everyone of us may contribute to improving the lives of patients with cardiac arrhythmias. This is what drives us to come to work every single day. Many of us also enjoy the natural scene and conviviality in Marseille. You may find us celebrating milestones nearby (or on!) the Mediterranean sea.
If you are inspired, feel free to reach out! We would love to review your application.
Développeur / Concepteur H/F
Marseille, France
Développeur / Concepteur H/F
Qui sommes-nous ?
Volta Médical est une start-up dont le siège est à Marseille et dont le but est de fournir toute une gamme de logiciels intelligents qui viendront guider le cardiologue pendant les interventions chirurgicales (de type ablation). La création de l’entreprise fait suite à la découverte d’une nouvelle procédure médicale pour traiter la fibrillation atriale (l’arythmie cardiaque la plus fréquente au monde) par les fondateurs de l’entreprise experts mondiaux en rythmologie interventionnelle et analyse des signaux intracardiaques.
Afin d’automatiser cette procédure complexe qui est le fruit de dizaines d’années de recherche, nous développons un logiciel d’intelligence artificielle. Nous nous sommes lancés dans cette belle aventure il y a quatre ans et amorçons une phase de croissance rapide, raison pour laquelle nous recrutons un développeur talentueux !
Missions
1) Conception et mise à jour des différentes versions du logiciel (développement, test et production).
2) Développement et implémentation de nouveaux modules R&D (développés par l’équipe Data Science).
Compétences recherchées
– TypeScript, React, Node, Python
– GIT
– Test unitaire (Jest)
– Documentation
– Using type systems
– Using refactorings
Nous recherchons un profil qui aime travailler en équipe:
– Code review
– Peer programming
– Humilité et bienveillance
Compétences additionnelles appréciées
– Docker
– Linux
– C++, Kotlin, Rust
Profil recherché
Passionné par la programmation avec la volonté d’en connaître toujours plus.
Facilité à s’intégrer dans une équipe Agile pluridisciplinaire avec des profils variés.
Dynamique, enthousiaste et volontaire avec un intérêt pour la médecine et les nouvelles technologies.
Comment nous travaillons :
– L’équipe fonctionne en processus agile : itérations, réunions quotidiennes, revues de code, tests automatisés et intégration continue.
– Notre activité est structurée autour d’un outil de gestion de tickets et de dépôts Git.
– Notre domaine impose une démarche qualité importante.
– Nous écrivons la plupart de notre code en TypeScript, Python et C++, et envisageons d’utiliser Kotlin et Rust pour de prochains développements.
Conditions et processus de recrutement
Poste en CDI statut cadre basé à Marseille 6ème. Vous souhaitez en savoir plus?
N’hésitez pas à envoyer votre CV sur: hr@volta-medical.com
Senior Clinical Research Scientist H/F
Marseille, France
Senior Clinical Research Scientist H/F
Who are we ?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during electrophysiology procedures.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and US working in a great environment in order to make difference on the health market. Our main product is a therapeutic solution using data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 40 employees! We raised a $31 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination.
We recruit, employ, train, compensate, and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status or any other characteristic protected by law.
Missions
Volta is looking for an innovative clinical and scientific expert reporting directly to the VP of Clinical & Regulatory Affairs who will be responsible for:
– Developing the publication planning/strategy and supporting the dissemination of scientific/clinical data through strategically aligned scientific communications (manuscripts, abstracts, conference presentations) by providing scientific expertise and authoring support as required.
– Conducting and preparing literature reviews and clinical watch.
– Helping design clinical studies: define appropriate hypotheses, study rationale, measurable endpoints, and methods to ensure scientific integrity of the study in accordance with current regulations, guidelines and practices.
– Ensuring scientific integrity of clinical study data by assisting in the development of study plans, data collection, review, and analysis materials (e.g., CRFs, statistical analysis plans, TLFs).
– Providing support in the development of program documents, author and/or critically review regulatory and clinical documents, including clinical plans, pre-submission documents, clinical study protocols and reports, and responses to regulatory agencies or institutional review boards/ethics committees.
– Reviewing, analyzing and interpreting study data; prepare and present data summaries, reports.
– Contributing ideas for business proposals and new projects
– Collaborating with a variety of internal and external partners and stakeholders, such as clinical investigators, KOLs and biostatisticians, as well as multidisciplinary internal teams (Clinical, Medical, Regulatory, R&D, business development, commercial operations, legal, etc.)
Profile:
– PhD (preferred) or master’s degree in biomedical sciences,
– Minimum of 6 years related industry experience in Medical Device or Pharmaceuticals including analyzing, interpreting, and summarizing clinical data for internal and external audiences.
– Experience with feasibility and pivotal clinical studies
– Ability to interpret study results and perform data analyses
– Proficient knowledge of medical terminology
– Demonstrated understanding of human physiology and cardiac electrophysiology
– Working knowledge of statistics to apply and understand appropriate study design and data analysis of clinical trials, demonstrated experience using statistical software (e.g., R, Matlab, SAS)
– Expertise with GCP and regulatory compliance guidelines for clinical trials
– Must have excellent working knowledge of Word, Excel, PowerPoint, reference management systems
– Advanced scientific writing skills
– Fluent in English,
– Good level in French,
Soft skills
– Strong problem-solving aptitude
– Intellectual curiosity
– Good communication skills
– High attention to details
– Ability to manage multiple tasks and ensure adherence to timelines
– Ability to work effectively independently and with cross-functional teams
Why should you join?
– AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
– You will get an opportunity to work with a highly diverse, motivated and experienced team,
– Opportunity to experience the Mediterranean lifestyle. It is great if you enjoy nature and the ocean!
Conditions and recruitment process
The position is on a full-time CDI, “cadre” status, Fully remote work possible.
Does this sound exciting to you? Then do not hesitate to apply! Please send your resume to hr@volta-medical.com
Product Owner H/F
Marseille, France
Product Owner H/F
Who we are?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during heart surgeries.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and the US working in a great environment in order to make difference in the health market. Our main product is a therapeutic solution using the data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 40 employees! We raised a $31 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination.
We recruit, employ, train, compensate and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status, or any other characteristic protected by law.
Mission
Under the supervision of the Head of product, the Product Owner will be working together with the software engineering team to :
● Define user stories and their acceptance criteria
● Participate as the product owner in agile ceremonies and act as a liaison between the development team and the product team
● Contribute to product backlog management: ensure prioritized features are developed
● Gather requirements from stakeholders and define use cases
● Contribute to regulatory artifacts documentation (user, technical requirements)
● Work in close collaboration with test team to ensure requirements are covered
● Support product team with product validation
● Contribute to defining product roadmap and priorities working closely with the head of product
● Understand the competition landscape
● Help marketing team with marketing material
Profile
● Engineering degree (MSc) in biomedical or computer science,
● Basic knowledge (or interest and willingness to learn) of web architecture, software development
● At least 2-3 years experience in a product owner/ product management role within the MedTech industry (medical device industry is a plus)
● Demonstrate/proven experience with software delivery
● Well versed with software development methodology (V-cycle, agile methodology)
● Experience working with issues management tools such as Jira, Confluence
● Communicates effectively in written and oral English and french
● Excellent collaboration and communication skills, with the ability to present and defend your ideas to stakeholders
● Enjoy working with the software engineering team and fast learner
● Proactive in finding creative solutions to challenging problems
● Knowledge of ISO 13485, IEC 62304, IEC 82304-1 is a plus
● A certified scrum product owner is a plus
Why should you join?
– AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
– You will get an opportunity to work with a highly diverse, motivated, and experienced team,
– Opportunity to experience the Mediterranean lifestyle. It is great if you enjoy nature and the ocean!
Condition and recruitment process
The position is on CDI, based in Marseille 6th (on the 17th Floor of a Tour Méditerranée).
Do you want to know more about our team?
We will evaluate your application soon as possible. Please send her your resume: hr@volta-medical.com
Tech Recruiter / Talent Acquisition H/F
Marseille, France
Tech Recruiter / Talent Acquisition H/F
Who we are?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during heart surgeries.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and US working in a great environment in order to make difference on the health market. Our main product is a therapeutic solution using data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 40 employees! We raised a $31 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination.
We recruit, employ, train, compensate, and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status or any other characteristic protected by law.
Mission
Working closely with the HR Manager, you will be responsible for:
• Direct sourcing and pipelining talent at all levels, mainly for R & D Team (developers, data scientist and software product management roles),
• Working closely with relevant areas of the business to understand their recruitment needs, and to add value to the existing recruitment framework, tools, and processes,
• Providing support, guidance, and advice to internal managers, on all recruitment and talent matters,
• Genuinely care about the employee and candidate experience, with a warm, heartfelt and solution focused approach.
Profile
● A first experience as tech recruiter (at least an internship),
● In-depth understanding of the various Research & Development roles and skill sets in software engineering (for instance coding languages), product management and data science,
● In-depth understanding of the academic landscape in software engineering, product management and data science (main universities and academic pathways),
● Be able to think and create an adapted sourcing strategy depending on the profile you are looking for,
● Knowledge in Lever ATS is a plus,
● High level of Emotional Intelligence,
● Organized, Creative and Combative.
Why should you join?
– AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
– You will get an opportunity to work with a highly diverse, motivated and experienced team,
– Opportunity to experience the Mediterranean lifestyle. It is great if you enjoy nature and the ocean!
Condition and recruitment process
The position is on CDI, based in Marseille 6th (on the 17th Floor of a Tour Mediterranée)
Do you want to know more about our team?
We will evaluate your application soon as possible. Please send her your resume: hr@volta-medical.com
Senior Test Engineer (test Leader) H/F
Marseille, France
Senior Test Engineer (test Leader) H/F
Who are we ?
Volta Medical is an AI medtech startup. Volta has developed the first AI software to guide
physicians in atrial fibrillation (AF) treatment during a curative intervention called ablation. With 11 million patients in the EU alone (14-17 million in 2030) and 33 million patients worldwide, AF is the most common arrhythmia (irregular heart rhythm) in adults and ablation is currently one of the most advanced treatment options.
After 15+ years of research, Volta Medical has developed a product using a data-driven approach for optimal real-time identification of dispersion zones during atrial fibrillation ablation. This solution is built on artificial intelligence (AI, deep and machine learning) approaches to gain insight into innovative therapies for AF.
Volta is based in Marseille and has international presence in the USA. Our mission is to provide a range of intelligent and innovative softwares that will guide the cardiologist during surgical procedures in the operating room. We have recently raised our series A round and the team now consists of more than 30 collaborators with a branch in the United States. We embarked on this adventure more than four years ago and are entering another phase of rapid growth.
At Volta Medical we believe in maintaining high standards, agility and proactivity in our work. We have a multicultural team, embracing diversity and gender balance at the workplace.
Responsibilities
You will join a highly skilled technical team composed of data scientists and developers using the
Agile Method. In this context, you will:
➔ Create test strategies, test plans and test cases for on-going projects
➔ Contribute to test execution campaigns planning and execution, including smoke test and
regression testing, problem reporting (defect management),
➔ Set up test environments, test management software
➔ Ensure proper traceability and test coverage
➔ Monitor test execution, report the status through progress and quality metrics
Additionally, you will collaborate with the management team and technical leads on the following topics:
➔ Definition and improvement of test policies,
➔ Identification and planning of test resources
➔ Increased adoption of automated testing : identifying automation opportunities, setting up common practices, training, selecting tools and frameworks
Required Experience
– at least 5 years’ experience as a software test engineer, or 1 year as Test Leader, in a
regulated environment
Valued Experience
– Experience in the Medical Device industry
– Usability and cybersecurity testing,
– ISTQB,
– experience with agile development.
Soft skills
– Problem-solving aptitude
– Strong verbal and written communication skills
– Rigor, attention to details
Why should you join?
– AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
– You will get an opportunity to work with a highly diverse, motivated and experienced team,
– Opportunity to experience the Mediterranean lifestyle. It is great if you enjoy nature and the ocean!
Recruitment process
The position is on a full-time CDI, “cadre” status, based in Marseille 6th.
Does this sound exciting to you? Then do not hesitate to apply!
Send your resume: hr@volta-medical.com
Développeur – Concepteur Senior H/F
Marseille, France
Développeur – Concepteur Senior H/F
Qui sommes-nous ?
Volta Médical est une start-up dont le siège est à Marseille et dont le but est de fournir toute une gamme de logiciels intelligents qui viendront guider le cardiologue pendant les interventions chirurgicales (de type ablation). La création de l’entreprise fait suite à la découverte d’une nouvelle procédure médicale pour traiter la fibrillation atriale (l’arythmie cardiaque la plus fréquente au monde) par les fondateurs de l’entreprise experts mondiaux en rythmologie interventionnelle et analyse des signaux intracardiaques.
Afin d’automatiser cette procédure complexe qui est le fruit de dizaines d’années de recherche, nous développons un logiciel d’intelligence artificielle. Nous nous sommes lancés dans cette belle aventure il y a quatre ans et amorçons une phase de croissance rapide, raison pour laquelle nous recrutons un développeur senior talentueux !
Dans l’exercice de vos fonctions, vous devrez (entre autres):
– Concevoir et développer les différentes versions du logiciel.
– Développer et maintenir des briques logicielles d’acquisition de signal.
– Aider au développement et au portage d’algorithmes de Data Science.
Nous serons heureux de vous avoir dans notre équipe si vous :
– Aimez résoudre des problèmes complexes et ambitieux.
– Avez au moins 4 ans d’expérience professionnelle dans le développement logiciel.
– Avez une bonne expérience de la programmation système.
– Pouvez concevoir et écrire du code facile à lire et à maintenir.
– Avez un fort esprit d’équipe, êtes ouverts à des opinions divergentes, et pouvez argumenter votre point de vue avec un raisonnement solide.
– Etes capable d’échanger en anglais à l’écrit et à l’oral.
Nous serons particulièrement ravis si vous :
– Avez préalablement développé en C, C++ ou Rust.
– Avez des connaissances sur des langages de plus haut niveaux comme Python, Javascript et/ou TypeScript.
– Êtes familier avec le traitement de signal et/ou la Data Science.
Comment nous travaillons :
– L’équipe fonctionne en processus agile : itérations, réunions quotidiennes, revues de code, tests automatisés et intégration continue.
– Notre activité est structurée autour d’un outil de gestion de tickets et de dépôts Git.
– Notre domaine impose une démarche qualité importante.
– Nous écrivons la plupart de notre code en TypeScript, Python et C++, et envisageons d’utiliser Kotlin et Rust pour de prochains développements.
Conditions et processus de recrutement
Poste en CDI statut cadre basé à Marseille 6ème. Vous souhaitez en savoir plus?
N’hésitez pas à envoyer votre CV sur: hr@volta-medical.com
DevOps Engineer H/F
Marseille, France
DevOps Engineer H/F
Who are we ?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during heart surgeries.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and US working in a great environment in order to make difference on the health market. Our main product is a therapeutic solution using data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 40 employees! We raised a $31 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination.
We recruit, employ, train, compensate, and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status or any other characteristic protected by law.
Responsibilities
You will join a highly skilled technical team composed of data scientists and developers working with the Agile Methodology.
In the context of a significant growth of the R&D team, your main mission will be to build, deploy and maintain a state of the art Continuous Integration framework which can serve the needs of all current and future projects (products, data collection tools, data science modules) : automated build and deployment, automated unit and functional testing, automated and comprehensive dashboards.
You will
– Assess existing CI/CD tools, propose, and implement improvements,
– Watch DevOps trends, suggest new tools and practices, implement, and deploy them
– Support the R&D team in the use of the platform,
– Develop key automated tests,
– Promote automated test adoption in the teams through use of common practices and tools.
Required Experience
– Good knowledge of DevOps culture and experience in DevOps operations
– Experience in Linux system administration, wired and wireless networks
– Containers and virtual machines: Docker, Swarm
– Experience in managing the security of sensible databases with appropriate tools
Valued Experience
– Machine Learning context
– GitLab
– AWS
– Vault
– ELK/EFK
– K8S
Soft skills
– Problem-solving aptitude
– Knowledge of technological trends and threats
– Good communication skills
– Attention to details
Recruitment process
The position is on a full-time CDI, “cadre” status, based in Marseille 6th.
Does this sound exciting to you ? Then do not hesitate to apply!
Loren Siry will assess your application as soon as possible.
Do not hesitate to send her your resume/CV: hr@volta-medical.com
Signal Processing Engineer H/F
Marseille, France
Signal Processing Engineer H/F
Who are we ?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during heart surgeries.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and US working in a great environment in order to make difference on the health market. Our main product is a therapeutic solution using data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 35 employees! We raised a $31 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
At Volta Medical we believe in maintaining high standards, agility and proactivity in our work. We have an enthusiastic multicultural team, embracing diversity and gender balance at the workplace.
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination. We recruit, employ, train, compensate, and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status or any other characteristic protected by law.
Job brief
We are looking for a Signal Processing Engineer to be a part of our R&D team. Solid technical background and interest in AI for health applications are essential in this role.
You will be part of a technical team of around 12 people (8 Developers and 4 Data Scientists). In this context, you will:
➔ Build state of the art machine learning algorithms to be used in the operation room (EP Lab),
➔ Participate in the effort to develop better data collecting tools suited to the constraints of the health domain.
➔ Participate in the production of necessary regulatory documents for the clearance / approval of the developed softwares.
➔ Produce code of high quality (coding guidelines, unit tests, etc.),
➔ Participate in scientific congresses.
Required Profile
– Graduate from a master’s / engineering school (BAC + 5), in mathematics, physics, data science or statistics,
– At least 1 year of experience in Machine Learning R&D projects Managerial, strategic and soft skills
– Problem-solving aptitude
– Ability to conduct technological analyses and research
– Excellent communication skills
– Excellent organizational and time-management skills
– Attention to details.
– Interested in the recent developments of AI / ML research
Technical experience
– Very good academic level in machine learning (mathematical and algorithmic background, good practices in ML, Deep learning, Classical machine learning algorithms, Signal processing, etc …)
– Computer Science (Complexity calculation, parallel programming)
– Python (PyTorch, Tensorboard, Pandas, numpy, asyncio, Pytest, scikit-learn, XGBoost, etc…)
– GIT
– Docker
– Database
– Linux
– Very good level in English
These technologies are not required but would be appreciated:
– PostgreSQL
– Advanced knowledge in computer science (Dynamic programming, socket communication protocols, etc …)
– Code optimization in python (Numba / Cython)
– Lower level computer language knowledge (C, Assembly, etc…)
– Have participated in the publication of a scientific article
Why should you join?
AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
You will get an opportunity to work with a highly diverse, motivated and experienced team,
Opportunity to experience the Mediterranean lifestyle. It is great if you enjoy nature and the ocean!
Recruitment process
The position is on a full-time CDI, “cadre” status, based in Marseille 6th. Do you want to apply and know more about our team: hr@volta-medical.com
Field Technical Engineer H/F
Marseille, France
Field Technical Engineer H/F
Who we are?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during heart surgeries.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and US working in a great environment in order to make difference on the health market. Our main product is a therapeutic solution using data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 35 employees! We raised a $27 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination.
We recruit, employ, train, compensate, and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status or any other characteristic protected by law.
Mission
Under the supervision of the Head of Sales, the Field Technical Engineer will be responsible for:
● Deploy and install our solutions at hospitals,
● Oversee application support during operations with surgeons (especially during the deployment of our clinical studies),
● Train doctors and teams on-site to use our solutions,
● Be the first point of contact with our customers,
● Play a central role in customer relations and loyalty. You are the ambassador of our products.
Profile
● Engineering degree (Msc) in biomedical,
● First experience (at least an internship) in a similar role,
● English written and spoken.
Why should you join?
– AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
– You will get an opportunity to work with a highly diverse, motivated, and experienced team,
Condition and recruitment process
The position is on CDI, fully remote with frequent travel through France, Germany, Belgium, and Netherlands.
Do you want to know more about our team? So, let’s apply!
We will evaluate your application soon as possible. Please send her your resume: hr@volta-medical.com
Signal Processing Expert H/F
Marseille, France
Signal Processing Expert H/F
Who are we ?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during heart surgeries.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and US working in a great environment in order to make difference on the health market. Our main product is a therapeutic solution using data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 35 employees! We raised a $31 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
At Volta Medical we believe in maintaining high standards, agility and proactivity in our work. We have an enthusiastic multicultural team, embracing diversity and gender balance at the workplace.
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination. We recruit, employ, train, compensate, and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status or any other characteristic protected by law.
Job brief
We are looking for a Signal Processing Expert to be a part of our R&D team. Strong technical background and experience in AI for health applications are essential in this role.
Responsibilities
You will be part of a technical team of around 12 people (8 Developers and 4 Data Scientists). In this context, you will:
➔ Formulate, suggest and manage data driven projects according to business priorities
➔ Communicate technology strategy to partners and investors
➔ Build state of the art machine learning algorithms to be used in the operating room (EP Lab)
➔ Contribute to the development of data collecting tools suited to the constraints of
the health domain.
➔ Produce regulatory documents required for the clearance /
approval of the developed algorithms.
➔ Produce code of high quality (coding guidelines, unit tests, etc.)
➔ Participate in scientific congresses
Required Profile
– Graduate from a master’s / engineering school (BAC + 5), in mathematics, physics, data
science or statistics,
– 5-10 years of experience in Machine Learning R&D projects
Managerial, strategic and soft skills
– Problem-solving aptitude
– Ability to conduct technological analyses and research
– Team player attitude
– Supervision and mentoring skills
– Excellent communication skills
– Excellent organizational and time-management skills
Technical experience
– Aware of recent developments of AI / ML research
– Excellent academic level in machine learning (mathematical and algorithmic background,
good practices in ML, Deep learning, Classical machine learning algorithms, Signal processing, etc …)
– Good background in SW Engineering practices, Agile methodology
– Python (PyTorch, Tensorboard, Pandas, numpy, asyncio, Pytest, scikit-learn, XGBoost, etc…)
– GIT, Docker, Linux
– Very good level in English
These skills are not required but would be appreciated:
– PostgreSQL
– Advanced knowledge in computer science (sockets, multi-threading, GPU, etc …)
– Code optimization in python (Numba / Cython)
– Lower level computer language knowledge (C, Assembly, etc…)
– Experience in scientific publications & patents
Why should you join?
AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
You will get an opportunity to work with a highly diverse, motivated and experienced team,
Opportunity to experience the Mediterranean lifestyle. It is great if you enjoy nature and the ocean!
Recruitment process
The position is on a full-time CDI, “cadre” status, based in Marseille 6th. Do you want to apply and know more about our team?
Send your CV to hr@volta-medical.com If your CV is accepted, our HR will contact you for a first phone conversation.
Candidates who will unfortunately not be selected will receive an email.
Science
ABOUT Atrial Fibrillation
The heart beats are generated by the sino-atrial node, a small tissue region in the right atrium. The propagation of impulses to both upper chambers of the heart – i.e the two atria – causes them to contract and move the blood to the lower chambers of the heart, a.k.a the ventricles.
Atrial fibrillation (AF) is the most common heart rhythm disturbance in adults. AF is caused by abnormal electrical impulses forming anywhere in the atria. AF may be recorded on an electrocardiogram (ECG). The beating heart of AF patients is fast and irregular.
Physicians classify AF according to the duration of arrhythmia episodes. Brief episodes correspond to paroxysmal AF. Longer episodes are known as persistent AF.
ABOUT Interventional electrophysiology
Interventional electrophysiology is a surgical specialty. It requires multiple years of experience and consists of conducting intra-cardiac procedures to cure cardiac arrhythmias such as atrial fibrillation.
During an intervention, an electrophysiologist is required to analyze a large amount of information in real-time. First, an accurate visual analysis of up to 30 electrograms is essential. Then, non-electrogram information coming from multiple sources needs additional consideration.
All data allow for seamless progress through the multiple-step procedural workflow.
